These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27677767)

  • 21. Asymmetric Synthesis of Spirocyclic 2-Benzopyrans for Positron Emission Tomography of σ1 Receptors in the Brain.
    Holl K; Schepmann D; Fischer S; Ludwig FA; Hiller A; Donat CK; Deuther-Conrad W; Brust P; Wünsch B
    Pharmaceuticals (Basel); 2014 Jan; 7(1):78-112. PubMed ID: 24451404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of spirocyclic sigma1 receptor ligands as potential PET radiotracers, structure-affinity relationships and in vitro metabolic stability.
    Grosse Maestrup E; Wiese C; Schepmann D; Hiller A; Fischer S; Scheunemann M; Brust P; Wünsch B
    Bioorg Med Chem; 2009 May; 17(10):3630-41. PubMed ID: 19394833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats.
    Olberg DE; Bauer N; Andressen KW; Hjørnevik T; Cumming P; Levy FO; Klaveness J; Haraldsen I; Sutcliffe JL
    Nucl Med Biol; 2016 Aug; 43(8):478-89. PubMed ID: 27236283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of PET radiometabolites by cytochrome P450, UHPLC/Q-ToF-MS and fast radio-LC: applied to the PET radioligands [11C]flumazenil, [18F]FE-PE2I, and [11C]PBR28.
    Amini N; Nakao R; Schou M; Halldin C
    Anal Bioanal Chem; 2013 Feb; 405(4):1303-10. PubMed ID: 23180082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tactics for preclinical validation of receptor-binding radiotracers.
    Lever SZ; Fan KH; Lever JR
    Nucl Med Biol; 2017 Jan; 44():4-30. PubMed ID: 27755986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
    Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.
    Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH
    Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying novel radiotracers for PET imaging of the brain: application of LC-MS/MS to tracer identification.
    Barth V; Need A
    ACS Chem Neurosci; 2014 Dec; 5(12):1148-53. PubMed ID: 24828747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.
    Khayum MA; Doorduin J; Antunes IF; Kwizera C; Zijlma R; den Boer JA; Dierckx RA; de Vries EF
    Nucl Med Biol; 2015 Jun; 42(6):561-9. PubMed ID: 25735222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and structure-affinity relationships of regioisomeric N-benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands.
    Moussa IA; Banister SD; Beinat C; Giboureau N; Reynolds AJ; Kassiou M
    J Med Chem; 2010 Aug; 53(16):6228-39. PubMed ID: 20662542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
    Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
    J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel plasma protein binding analysis method for a PET tracer and its radiometabolites: A case study with [
    Aarnio R; Alzghool OM; Wahlroos S; O'Brien-Brown J; Kassiou M; Solin O; Rinne JO; Forsback S; Haaparanta-Solin M
    J Pharm Biomed Anal; 2022 Sep; 219():114860. PubMed ID: 35738120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
    Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET.
    Vicidomini C; Panico M; Greco A; Gargiulo S; Coda AR; Zannetti A; Gramanzini M; Roviello GN; Quarantelli M; Alfano B; Tavitian B; Dollé F; Salvatore M; Brunetti A; Pappatà S
    Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
    Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
    Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A ¹⁸F-labeled fluorobutyl-substituted spirocyclic piperidine derivative as a selective radioligand for PET Imaging of sigma₁ receptors.
    Maisonial A; Grosse Maestrup E; Fischer S; Hiller A; Scheunemann M; Wiese C; Schepmann D; Steinbach J; Deuther-Conrad W; Wünsch B; Brust P
    ChemMedChem; 2011 Aug; 6(8):1401-10. PubMed ID: 21618432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling: part II: Metabolism studies.
    Peyronneau MA; Saba W; Dollé F; Goutal S; Coulon C; Bottlaender M; Valette H
    Nucl Med Biol; 2012 Apr; 39(3):347-59. PubMed ID: 22154687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicinal Chemistry of σ
    Weber F; Wünsch B
    Handb Exp Pharmacol; 2017; 244():51-79. PubMed ID: 28620761
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.